Hotchkis & Wiley Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.11M Buy
+136,800
New +$8.88M 0.03% 293
2022
Q4
Sell
-178,230
Closed -$8.88M 533
2022
Q3
$8.88M Buy
178,230
+90,830
+104% +$5.03M 0.04% 146
2022
Q2
$5.14M Buy
87,400
+1,700
+2% +$93.7K 0.02% 315
2022
Q1
$4.54M Buy
85,700
+10,550
+14% +$609K 0.01% 383
2021
Q4
$4.56M Buy
+75,150
New +$4.46M 0.01% 364

Other funds holding PBH

Hotchkis & Wiley Capital Management's PBH Position: Q1 2026 in Review

Hotchkis & Wiley Capital Management opened a new position in Prestige Consumer Healthcare (PBH) in Q1 2026: 136,800 shares worth $8.11M. The stake represents 0.03% of the portfolio and ranks #293 among its holdings. This is a return to the name: Hotchkis & Wiley Capital Management previously reported a position in PBH as recently as Q3 2022.

Hotchkis & Wiley Capital Management first reported a position in PBH in Q4 2021 and has held it in 5 quarters since. The position peaked at $8.88M in Q3 2022. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Hotchkis & Wiley Capital Management held 136,800 shares of Prestige Consumer Healthcare worth $8.11M as of Q1 2026.
  • Prestige Consumer Healthcare was a new Hotchkis & Wiley Capital Management position in Q1 2026.
  • Prestige Consumer Healthcare made up 0.03% of Hotchkis & Wiley Capital Management's portfolio in Q1 2026, its #293 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2021 and has held it in 5 quarters since.
  • Hotchkis & Wiley Capital Management's Prestige Consumer Healthcare position peaked at $8.88M in Q3 2022.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.